Ali Helmi Bakri1, Mohammed H Hassan2, Ahmed El-Abd Ahmed1, Ghallab Alotaibi3, Pola Rafat Halim1, Ahmed Alamir Mahmoud Abdallah4, Nagwan I Rashwan1. 1. Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt. 2. Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, 83523, Egypt. mohammedhosnyhassaan@med.svu.edu.eg. 3. Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Shaqra, Saudi Arabia. 4. Medical Biochemistry Department, Faculty of Medicine, Sohag University, Sohag, Egypt.
Abstract
BACKGROUND: Epilepsy is one of the most common neurological disorders, and it places a significant economic strain on the healthcare system around the world. Although the exact mechanism of epilepsy has yet to be illustrated, various pathogenic cascades involving neurotransmitters and trace elements have been reported. We aimed to investigate the serum levels of growth-associated protein-43 (GAP-43) and neurotrophin-3 (NT-3) among cohort of Egyptian children with epilepsy and correlate these biomarkers with their zinc levels. METHODS: This case-control study included 50 pediatric patients with epilepsy who were comparable with 50 controls. Neurological assessment and electroencephalogram (EEG) were done to all included children. Biochemical measurements of serum GAP-43 and NT-3 using enzyme linked immunosorbent assays (ELISA), and total antioxidant capacity (TAC) and zinc using colorimetric assays, were performed to all participants. RESULTS: There was significantly frequent positive parental consanguinity among cases with significantly frequent generalized onset seizures (94%) than simple partial seizure (6%). There were significantly lower serum GAP-43 and zinc levels with significantly higher TAC among cases vs. the controls, p˂0.05 for all. There was no significant difference in the serum levels of NT-3 among epileptic children vs. the controls, p = 0.269. Serum Zn was positively correlated with GAP-43 level among epileptic children (r = 0.381, p = 0.006). Serum GAP-43 in diagnosing childhood epilepsy at cut-off point ≤ 0.6 ng/mL showed 78% sensitivity, 62% specificity, positive predictive value (PPV) = 50.6%, negative predictive value (NPP) = 84.9% with AUC = 0.574. CONCLUSION: GAP-43 can be considered a sensitive good negative biomarker in childhood epilepsy which correlated positively with the zinc status.
BACKGROUND: Epilepsy is one of the most common neurological disorders, and it places a significant economic strain on the healthcare system around the world. Although the exact mechanism of epilepsy has yet to be illustrated, various pathogenic cascades involving neurotransmitters and trace elements have been reported. We aimed to investigate the serum levels of growth-associated protein-43 (GAP-43) and neurotrophin-3 (NT-3) among cohort of Egyptian children with epilepsy and correlate these biomarkers with their zinc levels. METHODS: This case-control study included 50 pediatric patients with epilepsy who were comparable with 50 controls. Neurological assessment and electroencephalogram (EEG) were done to all included children. Biochemical measurements of serum GAP-43 and NT-3 using enzyme linked immunosorbent assays (ELISA), and total antioxidant capacity (TAC) and zinc using colorimetric assays, were performed to all participants. RESULTS: There was significantly frequent positive parental consanguinity among cases with significantly frequent generalized onset seizures (94%) than simple partial seizure (6%). There were significantly lower serum GAP-43 and zinc levels with significantly higher TAC among cases vs. the controls, p˂0.05 for all. There was no significant difference in the serum levels of NT-3 among epileptic children vs. the controls, p = 0.269. Serum Zn was positively correlated with GAP-43 level among epileptic children (r = 0.381, p = 0.006). Serum GAP-43 in diagnosing childhood epilepsy at cut-off point ≤ 0.6 ng/mL showed 78% sensitivity, 62% specificity, positive predictive value (PPV) = 50.6%, negative predictive value (NPP) = 84.9% with AUC = 0.574. CONCLUSION: GAP-43 can be considered a sensitive good negative biomarker in childhood epilepsy which correlated positively with the zinc status.
Authors: Michelle Y Cheng; Eric H Wang; Wyatt J Woodson; Stephanie Wang; Guohua Sun; Alex G Lee; Ahmet Arac; Lief E Fenno; Karl Deisseroth; Gary K Steinberg Journal: Proc Natl Acad Sci U S A Date: 2014-08-18 Impact factor: 11.205
Authors: Tahia H Saleem; Ghaydaa Ahmed Shehata; Rana Toghan; Hala M Sakhr; Ali Helmi Bakri; Tarek Desoky; Fatma Rabea A Hamdan; Nesma Foaud Mohamed; Mohammed H Hassan Journal: Neuropsychiatr Dis Treat Date: 2020-01-06 Impact factor: 2.570
Authors: Michael S Hildebrand; A Marie Phillips; Saul A Mullen; Paul A Adlard; Katia Hardies; John A Damiano; Verena Wimmer; Susannah T Bellows; Jacinta M McMahon; Rosemary Burgess; Rik Hendrickx; Sarah Weckhuysen; Arvid Suls; Peter De Jonghe; Ingrid E Scheffer; Steven Petrou; Samuel F Berkovic; Christopher A Reid Journal: Sci Rep Date: 2015-12-09 Impact factor: 4.379